Implementing a clinical pathway for the treatment of Medicare patients with cardiac chest pain.

M L Bing, R L Abel, K Sabharwal, C McCauley, K Zaldivar
{"title":"Implementing a clinical pathway for the treatment of Medicare patients with cardiac chest pain.","authors":"M L Bing,&nbsp;R L Abel,&nbsp;K Sabharwal,&nbsp;C McCauley,&nbsp;K Zaldivar","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>A small urban hospital identified angina pectoris (DRG 140) as a high-cost and low-reimbursement DRG. Variation in the process of care for patients with cardiac chest pain was related to the timing of decisions on stress tests and whether inpatient GI workups were performed. Underutilization of aspirin was identified as a quality of care issue. In collaboration with Texas Medical Foundation (TMF), the Quality Improvement Organization (QIO) for Texas, this became the initial Health Care Quality Improvement Program (HCQIP) project and the first effort by the hospital at pathway development.</p><p><strong>Intervention: </strong>A team effort lead by physicians, including other healthcare groups at the hospital, identified elements considered essential to providing ideal care for patients with cardiac chest pain, formulating these elements into a clinical pathway.</p><p><strong>Results: </strong>Emergency room physicians, an essential stakeholder group, had not been included in the initial pathway development, which proved to be a critical factor to effective implementation. Pathway implementation was associated with increased administration of aspirin by 45.7% (p < 0.001), reduced length of stay by 1.0 days (p = 0.064), and reduced total charges by an average of $1710.20 (p = 0.039).</p><p><strong>Discussion: </strong>These results suggest that process of care improvement, i.e., clinical pathway implementation, in collaboration with a QIO, contributed to reduced variation in the process of care. Participation by all stakeholders from the beginning in process of care improvement is essential.</p>","PeriodicalId":79476,"journal":{"name":"Best practices and benchmarking in healthcare : a practical journal for clinical and management application","volume":"2 3","pages":"118-22"},"PeriodicalIF":0.0000,"publicationDate":"1997-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Best practices and benchmarking in healthcare : a practical journal for clinical and management application","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: A small urban hospital identified angina pectoris (DRG 140) as a high-cost and low-reimbursement DRG. Variation in the process of care for patients with cardiac chest pain was related to the timing of decisions on stress tests and whether inpatient GI workups were performed. Underutilization of aspirin was identified as a quality of care issue. In collaboration with Texas Medical Foundation (TMF), the Quality Improvement Organization (QIO) for Texas, this became the initial Health Care Quality Improvement Program (HCQIP) project and the first effort by the hospital at pathway development.

Intervention: A team effort lead by physicians, including other healthcare groups at the hospital, identified elements considered essential to providing ideal care for patients with cardiac chest pain, formulating these elements into a clinical pathway.

Results: Emergency room physicians, an essential stakeholder group, had not been included in the initial pathway development, which proved to be a critical factor to effective implementation. Pathway implementation was associated with increased administration of aspirin by 45.7% (p < 0.001), reduced length of stay by 1.0 days (p = 0.064), and reduced total charges by an average of $1710.20 (p = 0.039).

Discussion: These results suggest that process of care improvement, i.e., clinical pathway implementation, in collaboration with a QIO, contributed to reduced variation in the process of care. Participation by all stakeholders from the beginning in process of care improvement is essential.

实施医保患者心源性胸痛的临床路径治疗。
背景:一家小型城市医院确定心绞痛(drg140)是一种高成本、低报销的DRG。心源性胸痛患者护理过程的变化与压力测试的决定时间和是否进行住院胃肠道检查有关。阿司匹林的利用不足被认为是一个护理质量问题。在与德州医学基金会(TMF)、德州质量改进组织(QIO)的合作下,这成为了最初的医疗质量改进计划(HCQIP)项目,也是医院在途径开发方面的第一次努力。干预:由医生领导的团队,包括医院的其他医疗保健小组,确定了为心源性胸痛患者提供理想护理所必需的要素,并将这些要素形成临床途径。结果:急诊室医生作为一个重要的利益相关者群体,在最初的路径制定中没有被纳入,这被证明是有效实施的关键因素。路径实施与阿司匹林给药量增加45.7% (p < 0.001)、住院天数减少1.0天(p = 0.064)、总费用平均减少1710.20美元(p = 0.039)相关。讨论:这些结果表明,与QIO合作的护理改善过程,即临床路径实施,有助于减少护理过程中的变化。所有利益攸关方从一开始就参与改善护理的过程至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信